Medscape: AFIRE encourages less antiplatelet use with novel oral anticoagulant for atrial fibrillation treatment
UC cardiologist weighs in on trial looking at therapies for heart patients
Medscape turned to the expertise of Richard Becker, MD, Director, UC Heart, Lung and Vascular Institute, when reporting the results of a randomized trial comparing an oral anticoagulation with an antiplatelet agent versus an oral anticoagulation alone in patients with both atrial fibrillation and stable coronary artery disease. Becker, also director of the UC Division of Cardiovascular Health and Disease in the College of Medicine and a UC Health cardiologist, authored a New England Journal of Medicine editorial on the results of the AFIRE trial.
Richard Becker, MD
Related Stories
Hoxworth, FC Cincinnati celebrate life-saving donors with exclusive May giveaway
April 27, 2026
Hoxworth Blood Center, University of Cincinnati, is asking donors to score big for their community this May with an exclusive 40 oz. FC Cincinnati–themed tumbler available to donors at the seven neighborhood donor centers and select mobile drives while supplies last.
UC works with local paramedics to advance sudden cardiac arrest research
April 24, 2026
A University of Cincinnati study demonstrates the feasibility of emergency medicine researchers partnering with community emergency medical services nationwide to investigate the causes of sudden cardiac arrest.
University of Cincinnati College of Medicine celebrates Class of 2026 at Honors Day
April 21, 2026
The UC College of Medicine celebrates the Class of 2026 at Honors Day. With a 100% residency match rate, 177 new MD, MD-PhD and MD-MPH graduates prepare for top-tier training nationwide.